Printer Friendly

PDA Announces Board of Directors Election Results.

BETHESDA, Md., Dec. 10, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) announced today the results of its 2014 Board of Directors election. PDA members voted for four volunteer directors over a period of three months this past fall.

Re-joining the Board for a second three-year term is:

* Ursula Busse, PhD, Head GxP Regulations Coordination, Group Quality External Relations, Novartis, will "work to strengthen PDA's presence in Europe and other regions of the world."

Joining the Board for a three-year term are:

* Former FDA official Deborah Autor, Sr. VP, Strategic Global Quality and Regulatory Policy at Mylan, is excited to "help PDA continue to be a leading organization for manufacturing science, quality, and innovation, as well as an important bridge between industry and regulators worldwide."

* Mashiro Akimoto, General Manager, Compliance Division, Toray Industries, looks forward to continuing "continue to encourage the use and sharing of PDA knowledge among membership by coordinating or facilitating interactive communication."

* Emma Ramnarine, Global Head, Biologics QC Network, Roche Pharma, plans to help "drive PDA's strategy from the board level and further strengthen PDA's collaboration with FDA, EMA, PIC/S and other health authorities."

" We are pleased to welcome to our Board of Directors four outstanding contributors to our Association and our industry," said PDA President Richard Johnson. "These volunteers will join an active and dedicated Board of Directors that has helped grow PDA's service to members over the past several years through strong leadership and collaboration with the PDA professional staff."

Each year, PDA members vote to fill spots on the volunteer Board of Directors and every other year, they also vote for the Board's officers.

The terms of three Directors came to an end in 2014: John Finkbohner, Junko Sasaki, and Chris Smalley.

"On behalf of PDA's 10,000 members, the Board of Directors, and the staff, I want to thank those Directors whose terms have concluded," Johnson said. "We look forward to their continued contribution to the community through their ongoing volunteerism in other PDA activities."

About PDA C Connecting People, Science and Regulation The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide. Go to to learn more.

Media Inquiries: Walt Morris, 301-656-5900, x. 148;

Logo -

To view the original version on PR Newswire, visit:</a>

SOURCE Parenteral Drug Association

COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 10, 2014
Previous Article:Jodi Robinson Joins Charter as Senior Vice President of User Experience Design and Development.
Next Article:Altair Announces 8th European Altair Technology Conference in Paris, France.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters